Phase II ZUMA-1: Interim Analysis of Anti-CD19 CAR T-Cell Therapy in Patients With Refractory Aggressive DLBCL

Read expert answers to clinician questions on optimizing the care of patients with CLL in today’s practice, from Clinical Care Options (CCO)

Ian W. Flinn, MD, PhD Susan M. O'Brien, MD John Pagel, MD, PhD Released: January 15, 2021

Expert answers to clinician questions on current challenges in managing patients with myelodysplastic syndromes (MDS), from Clinical Care Options (CCO)

Guillermo Garcia-Manero, MD Rami S. Komrokji, MD Jamile Shammo, MD, FASCP, FACP Released: January 11, 2021

Brief expert slideset from Clinical Care Options (CCO) on how and when to test for NTRK fusions in patients with head and neck cancer

Aarti Bhatia, MD, MPH Released: January 5, 2021

Brief expert slideset from Clinical Care Options (CCO) reviews current clinical trials of immunotherapies for patients with head and neck cancer

Barbara Burtness, MD Released: January 5, 2021